Morgan Stanley analyst David Risinger reiterated an Equalweight rating and $36.00 price target on Pfizer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Cantor Fitzgerald Reiterates Overweight Rating on Pfizer (PFE)July 23, 2020 7:01 AM Wave of promising study results raises hopes for coronavirus vaccinesJuly 20, 2020 2:49 PM Pfizer-BioNTech potential coronavirus vaccine shows promise in second early trialJuly 20, 2020 11:59 AM Mizuho 'Encouraged' by Pfizer (PFE) COVID-19 Vaccine DataJuly 20, 2020 10:57 AM Pre-Open Movers 07/20: (SRNE) (BNTX) (NBL) Higher; (NKLA) (MRNA) Lower (more...)July 20, 2020 9:33 AM Options expected to have increasing volume: PFE BNTX CVX NBLJuly 20, 2020 8:48 AM Moderna (MRNA) Trades Lower after Pfizer (PFE) and BioNTech (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response DataJuly 20, 2020 8:47 AM Pfizer (PFE), BioNTech SE (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine StudyJuly 20, 2020 8:46 AM Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response DataJuly 20, 2020 8:46 AM Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response DataJuly 20, 2020 8:45 AM Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response DataJuly 20, 2020 8:45 AM Pfizer (PFE), BioNTech (BNTX) Gain on Paper Discussing Ph1/2 Trial Results of its COVID-19 VaccineJuly 20, 2020 8:37 AM Wall Street closes higher, Nasdaq sets record as potential vaccines show promiseJuly 20, 2020 6:53 AM Pfizer (PFE), BioNTech SE (BNTX) Report Agreement with the U.K. for 30M Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 20, 2020 6:00 AM European stocks boosted by vaccine hopes, EU rescue fund optimismJuly 20, 2020 3:40 AM Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 20, 2020 1:01 AM Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2July 20, 2020 1:00 AM Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2July 20, 2020 1:00 AM Oil steady as virus infections rise but hopes for vaccine lends supportJuly 19, 2020 9:15 PM Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccinesJuly 17, 2020 7:29 AM